SC
NVX

Scholtz & Company’s NOVONIX NVX Stock Holding History

Scholtz & Company’s Portfolio NVX Stock Details NVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,185
Closed -$328K – 56
2022
Q1 		$328K Buy
+17,185
New +$283K 0.13% 49

Other funds holding NVX

AIS
AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Scholtz & Company's NVX Position: Q2 2022 in Review

Scholtz & Company sold out of NOVONIX (NVX) in Q2 2022, closing a stake of 17,185 shares — an estimated $328K sold.

Scholtz & Company first reported a position in NVX in Q1 2022 and held it in 1 quarter. The position peaked at $328K in Q1 2022. 8 funds tracked by Wall St. Rank hold NVX as of Q2 2022.

  • Scholtz & Company reported no remaining NOVONIX position as of Q2 2022 after selling out during the quarter.
  • Scholtz & Company sold 17,185 NOVONIX shares in Q2 2022, an estimated $328K.
  • Scholtz & Company first reported a position in NOVONIX in Q1 2022 and held it in 1 quarter.
  • Scholtz & Company's NOVONIX position peaked at $328K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held NOVONIX as of Q2 2022.

Based on Scholtz & Company's 13F filing for Q2 2022, filed 15 Aug 2022.